Homocysteine in coronavirus disease (COVID-19): a systematic literature review
- 14 April 2022
- journal article
- review article
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 9 (3) , 306-310
Abstract
Objectives: Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disorder characterized by a sustained prothrombotic state. Since homocysteine is a potential biomarker of thrombotic diseases, the aim of this article is to provide an updated overview on the possible role played by hyperhomocysteinemia in influencing an unfavorable COVID-19 progression. Methods: We carried out an electronic search in Medline (PubMed interface) using the keywords (“COVID-19” OR “SARS-CoV-2”) AND “homocysteine”, between 2019 and the present time, with no language restrictions, to identify all articles which explored the concentration of homocysteine in COVID-19 patients with or without unfavorable disease progression. Results: Three studies, totaling 694 hospitalized COVID-19 patients, were included in our systematic review. Overall, the differences between the mean homocysteine values in non-severe vs. severe COVID-19 patients were always positive (i.e., 15.1%, 24.1% and 22.8%, generating a positive weight mean difference of 1.75 μmol/L (95%CI, 1.26–2.25 μmol/L; p=0.011), which translates into a cumulative difference of approximately ∼1.2 μmol/L. Conclusions: Despite the limited evidence that has been garnered so far, increased homocysteine levels may be a potentially useful marker for predicting the risk of unfavorable progression in patients with COVID-19.Keywords
This publication has 28 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patientsAging, 2020
- Homocysteine-lowering interventions for preventing cardiovascular eventsCochrane Database of Systematic Reviews, 2017
- Homocysteine-Lowering Therapy and Risk for Venous ThromboembolismAnnals of Internal Medicine, 2007
- The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with DiseaseThe Journal of Nutrition, 2006
- Homocysteine and Renal DiseaseSeminars in Thrombosis and Hemostasis, 2000
- Homocysteine and Its Disulfide DerivativesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine ConcentrationsNew England Journal of Medicine, 1999
- Homocysteine and vitamins in cardiovascular diseaseClinical Chemistry, 1998
- The Leiden Thrombophilia Study (LETS)Thrombosis and Haemostasis, 1997